SCHEMBL3728405

SCHEMBL3728405

CC(C)(C)NCCC(=O)c1cccc(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 1/20 0.53
FEN1 P39748 1/20 0.53
SLC6A2 P23975 4/20 0.51
SLC6A3 Q01959 3/20 0.51
CHRNA1 P02708 1/20 0.51
CHRNG P07510 1/20 0.51
ITGA5 P08648 1/20 0.51
CHRNB1 P11230 1/20 0.51
CHRNB2 P17787 1/20 0.51
CHRNB4 P30926 1/20 0.51
SLC6A4 P31645 1/20 0.51
CHRNA3 P32297 1/20 0.51
CYP2C19 P33261 1/20 0.51
HRH1 P35367 1/20 0.51
CHRNA7 P36544 1/20 0.51
OPRK1 P41145 1/20 0.51
CHRNA4 P43681 1/20 0.51
CHRND Q07001 1/20 0.51
KCNH2 Q12809 1/20 0.51
ALDH1A1 P00352 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5615172 0.87 CYP2B6 (0.56) ERCC5FEN1SLC6A2SLC6A3CHRNA1
SCHEMBL9743797 0.82 ERCC5 (0.60) ERCC5FEN1ALDH1A1PARP1HSD11B1
SCHEMBL2542476 0.80 MAPT (0.52) ERCC5FEN1CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL634652 0.79 ERCC5 (0.53) ERCC5FEN1ALDH1A1PARP1MEN1
SCHEMBL634434 0.77 ERCC5 (0.57) ERCC5FEN1ALDH1A1SMN1; SMN2PARP1
SCHEMBL6266591 0.77 ERCC5 (0.50) ERCC5FEN1SLC6A2SLC6A3CHRNA1
SCHEMBL11791699 0.76 ERCC5 (0.76) ERCC5FEN1SMN1; SMN2PARP1MEN1
SCHEMBL29962144 0.76 ERCC5 (0.76) ERCC5FEN1SMN1; SMN2PARP1MEN1
SCHEMBL12221558 0.76 ERCC5 (0.56) ERCC5FEN1SLC6A2SLC6A3CHRNA1
SCHEMBL3317470 0.75 ERCC5 (0.59) ERCC5FEN1ALDH1A1BLMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010121022-A1 MONOAMINE REUPTAKE INHIBITORS RESEARCH TRIANGLE INSTITUTE (US) 2010-10-21 WO disclosed